Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLCShugeng Gao, Jie He, Jianming Ying et al.|Journal of Thoracic Oncology|2020Cited by 415
Two-year follow-up of single PD-1 blockade in neoadjuvant resectable NSCLC.Shugeng Gao, Jie He, Ning Li et al.|Journal of Clinical Oncology|2021Cited by 5